<DOC>
	<DOC>NCT01062100</DOC>
	<brief_summary>To evaluate the feasibility, acceptability and safety of using a molecular breast imaging (MBI) Gamma Camera in women at high risk of developing breast cancer</brief_summary>
	<brief_title>Study To Investigate the Feasibility and Safety of A Dedicated High Resolution Nuclear Breast Imaging Camera</brief_title>
	<detailed_description />
	<criteria>Females ≥18 years of age Undergoing annual breast MRI because of a high risk of breast cancer due to any of the following: Known BRCA1 or BRCA2 mutation carriers, or is untested for BRCA but is a first degree relative of a BRCA mutation carrier History of radiation to the chest between 1030 years of age (e.g. Hodgkin's Disease) History of Cowdens or Li Fraumeni Syndrome A first degree relative with Cowdens or Li Fraumeni Syndrome Prior breast biopsy positive for lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia or atypical ductal hyperplasia (ADH) Family history consistent with a hereditary breast cancer syndrome and estimated personal lifetime cancer risk ≥25% using the IBIS risk evaluator Pregnant or lactating History of invasive breast cancer or ductal carcinoma in situ (DCIS) Unable to undergo MRI because of: Renal dysfunction with an estimated creatinine clearance of &lt; 30 ml/min calculated using the CockcroftGault formula Implanted ferrous metal prostheses Claustrophobia Medical or psychological conditions that on assessment, make them unable to complete the procedure Known allergies to GadoliniumDTPA Known allergies to Sestamibi (Miraluma or Cardiolite) Prior bilateral mastectomy Prior breast biopsy or surgery within 3 months</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>breast cancer</keyword>
	<keyword>molecular breast imaging</keyword>
	<keyword>MRI</keyword>
	<keyword>gamma camera</keyword>
</DOC>